Ventilatory Burden Explored as New Measure for Sleep Apnea Analysis
Mount Sinai's newly developed ventilatory burden offers a potentially more effective alternative to the traditional AHI in assessing severity in sleep apnea patients.
Mount Sinai's newly developed ventilatory burden offers a potentially more effective alternative to the traditional AHI in assessing severity in sleep apnea patients.
A newly developed PET imaging agent can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to begin treatment sooner.
The Vitalograph Morgan PFT Series includes the VitaloROV and the VitaloLAB, which offer full PFT testing capabilities, including spirometry, DLCO, MBN2, and more.
BD received FDA emergency use authorization for its new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and respiratory syncytial virus (RSV).
Read MoreCedars-Sinai Cancer has launched a new Lung Cancer Screening Program designed to reach more patients, simplify the screening process and provide fast access to follow-up care.
Read MoreHere are five valuable tips to achieve reliable, accurate results when performing spirometry tests to diagnose or manage COPD.
Read MoreSmartphones equipped with a deep learning algorithm are capable of detecting blood oxygen saturation levels down to 70%, according to a proof-of-principle study published in npj Digital Medicine.
Read MoreWith age-appropriate instructions, school-aged children can successfully use a nasal swab to obtain their own COVID-19 test specimen, according to research published in JAMA.
Read MoreNIH researchers have found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability.
Read MoreA study, published in the Journal of Cystic Fibrosis, looks at early markers of cystic fibrosis.
Read MoreWerfen has released GEMweb Live, a real-time onscreen viewer of diagnostic test results for cardiac surgical procedures.
Read MoreResearch published in JAMA Network Open shows an increase in the proportion of African American patients screened in the first nine months after the USPTF 2021 Lung Cancer Screening Guidelines took effect.
Read MoreMGC Diagnostics has partnered with Bedfont Scientific Ltd to distribute the FeNObreath test monitor to hospitals and remote locations.
Read MoreVitalograph is celebrating 21 years of empowering respiratory research through clinical trials services, with international team members fundraising for local respiratory charities to mark the milestone.
Read MoreThe US Preventive Services Task Force recommends people without signs or symptoms of COPD should not be screened because it does not improve overall health.
Read More